share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Borgeson Blake
美股SEC公告 ·  06/28 07:18

牛牛AI助理已提取核心訊息

Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 25, 2024. The transaction was executed in the open market at a price of $9.5052 per share, resulting in a total sale value of approximately $108,806. Following the sale, Borgeson directly holds a total of 7,177,116 shares in the company. The sale reflects a direct ownership transaction and was completed as an open market or private sale.
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 25, 2024. The transaction was executed in the open market at a price of $9.5052 per share, resulting in a total sale value of approximately $108,806. Following the sale, Borgeson directly holds a total of 7,177,116 shares in the company. The sale reflects a direct ownership transaction and was completed as an open market or private sale.
Recursion Pharmaceuticals, Inc. [RXRX]關聯報告人Blake Borgeson於2024年6月25日完成了11,447股A類普通股的銷售。交易在市場上以每股9.5052美元的價格執行， resulting in a total sale value of approximately $108,806。銷售後，Borgeson直接持有該公司7,177,116股股份。該銷售反映了直接所有權交易，並作爲公開市場或私人銷售完成。
Recursion Pharmaceuticals, Inc. [RXRX]關聯報告人Blake Borgeson於2024年6月25日完成了11,447股A類普通股的銷售。交易在市場上以每股9.5052美元的價格執行， resulting in a total sale value of approximately $108,806。銷售後，Borgeson直接持有該公司7,177,116股股份。該銷售反映了直接所有權交易，並作爲公開市場或私人銷售完成。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間